Patient Guide: Obtain Safety and Effectiveness of CT-ACL001, a Regenerative Ligament Using Biological Tissue, in ACLR

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 6 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT07129694
Status: ENROLLING_BY_INVITATION
Condition: Anterior Cruciate Ligament Rupture
Phase: NA

Where You Can Participate

This study is available at 6 locations across the country.

Top locations include:
  • • Hirosaki, Aomori
  • • Sapporo, Hokkaido
  • • Kobe, Hyogo
  • • And 3 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Obtain Safety and Effectiveness of CT-ACL001, a Regenerative Ligament Using Biological Tissue, in ACLR - Join Clinical Trial NCTNCT07129694

How to Join This Clinical Trial - NCTNCT07129694

Learn how to participate in this NA trial studying an investigational therapy for Anterior Cruciate Ligament Rupture. Current status: ENROLLING_BY_INVITATION.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Anterior Cruciate Ligament Rupture. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Anterior Cruciate Ligament Rupture
Treatment Being Tested
Investigational treatment
Study Phase
NA - Research study
Enrollment Status
ENROLLING_BY_INVITATION
Study Identifier
NCTNCT07129694 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 6 locations. Find a study site near you:

Clinical Research Site

Hirosaki, Aomori 036-8563 - Japan

Status: Contact for availability

Clinical Research Site

Sapporo, Hokkaido 060-8648 - Japan

Status: Contact for availability

Clinical Research Site

Kobe, Hyogo 650-0017 - Japan

Status: Contact for availability

Clinical Research Site

Bunkyo-ku, Tokyo 113-0033 - Japan

Status: Contact for availability

Clinical Research Site

Shinjuku-ku, Tokyo 162-8666 - Japan

Status: Contact for availability

Clinical Research Site

Hiroshima, 734-8551 - Japan

Status: Contact for availability

How to Enroll in This Study

To learn more about participating in this NA clinical trial for Anterior Cruciate Ligament Rupture:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships